ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV)

Historical Holders from Q3 2020 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
ACHV on Nasdaq
Shares outstanding
51,599,531
Price per share
$3.15
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
15,541,415
Holdings value
$48,917,159
% of all portfolios
0%
Share change
-11,686,208
Value change
-$26,338,868
Average buys %
+0%
Average sells %
-0%
Number of holders
65
Price from insider filings
$2.92
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FRANKLIN RESOURCES INC 16% +26% $20,044,890 +$9,280,183 8,640,039 +86% Franklin Resources, Inc. 30 Jun 2025
Alyeska Investment Group, L.P. 5.6% -43% $9,395,574 -$6,098,715 2,982,722 -39% Alyeska Investment Group, L.P. 30 Sep 2025
Contrarian Alpha, LP 4.9% $7,964,388 2,528,377 Parker Quillen 30 Sep 2025
VANGUARD GROUP INC 5% $4,086,493 1,717,014 The Vanguard Group 31 Mar 2025
BlackRock, Inc. 0.6% $711,220 314,699 BlackRock, Inc. 30 Jun 2025
As of 30 Sep 2025, ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) has 65 institutional shareholders filing 13F forms. They hold 15,541,415 shares of 51,599,531 outstanding shares (30%) .

Top 25 institutional shareholders own 29% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Propel Bio Management, LLC 7.3% 3,786,425 -38% 12% $11,927,239
VANGUARD GROUP INC 4.8% 2,461,802 +15% 0% $7,754,676
Simplify Asset Management Inc. 2.3% 1,184,512 0% 0.08% $3,731,213
MARSHALL WACE, LLP 1.5% 774,853 0% $2,440,788
Nantahala Capital Management, LLC 1.3% 648,885 -28% 0.13% $2,043,988
GEODE CAPITAL MANAGEMENT, LLC 0.98% 506,977 +40% 0% $1,597,680
Pathstone Holdings, LLC 0.97% 502,000 0.01% $1,581,300
RAYMOND JAMES FINANCIAL INC 0.88% 456,372 +55% 0% $1,437,572
Clearline Capital LP 0.87% 451,219 -66% 0.12% $1,421,340
TWO SIGMA INVESTMENTS, LP 0.85% 439,064 0% $1,383,052
BlackRock, Inc. 0.76% 391,240 +24% 0% $1,232,406
Squarepoint Ops LLC 0.72% 373,079 +2677% 0% $1,175,199
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.71% 366,363 +404% 0% $1,154,043
LPL Financial LLC 0.64% 331,298 +29% 0% $1,043,589
RENAISSANCE TECHNOLOGIES LLC 0.6% 310,764 0% $978,907
Shay Capital LLC 0.56% 289,545 -1.1% 0.17% $912,067
MILLENNIUM MANAGEMENT LLC 0.46% 237,502 -39% 0% $748,131
GOLDMAN SACHS GROUP INC 0.43% 223,833 +274% 0% $705,074
STATE STREET CORP 0.43% 220,384 +40% 0% $694,210
NORTHERN TRUST CORP 0.43% 219,445 +1.7% 0% $691,251
Alyeska Investment Group, L.P. 0.35% 178,389 -95% 0% $561,925
ROYAL BANK OF CANADA 0.3% 154,720 +31% 0% $487,000
TWO SIGMA ADVISERS, LP 0.21% 110,300 0% $347,445
Blue Trust, Inc. 0.19% 99,130 0% $312,260
XTX Topco Ltd 0.17% 85,855 0.01% $270,443

Institutional Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 15,541,415 $48,917,159 -$26,338,868 $3.15 65
2025 Q2 26,238,674 $59,299,106 +$26,395,211 $2.26 64
2025 Q1 14,388,656 $38,412,610 -$6,420,566 $2.67 72
2024 Q4 16,340,748 $57,510,675 -$2,280,524 $3.52 70
2024 Q3 16,929,998 $81,217,159 +$2,394,591 $4.74 64
2024 Q2 12,513,128 $58,811,518 +$9,414,756 $4.70 54
2024 Q1 10,495,260 $47,701,835 +$35,368,247 $4.54 39
2023 Q4 2,727,493 $11,236,940 -$1,729,113 $4.12 29
2023 Q3 3,117,219 $13,403,691 -$2,279,792 $4.30 35
2023 Q2 3,562,232 $18,487,663 +$5,645,131 $5.19 38
2023 Q1 2,470,554 $16,600,668 +$3,392,110 $6.80 31
2022 Q4 1,999,698 $4,902,826 -$458,841 $2.45 27
2022 Q3 2,121,733 $7,001,230 +$176,107 $3.30 28
2022 Q2 2,043,015 $9,968,000 -$109,417 $4.88 31
2022 Q1 1,932,821 $14,633,000 -$2,149 $7.57 33
2021 Q4 1,918,795 $14,925,000 +$535,636 $7.78 26
2021 Q3 1,782,658 $15,149,000 -$1,185,059 $8.50 30
2021 Q2 1,948,272 $17,498,000 +$7,592,533 $8.98 28
2021 Q1 1,007,113 $11,662,000 +$6,322,912 $11.58 16
2020 Q4 493,003 $3,994,000 +$307,274 $8.10 14
2020 Q3 452,590 $3,789,000 +$3,789,000 $8.37 12